MANUSCRIPTS
Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted elsewhere before appearing in the Journal. This restriction does not apply to abstracts or press reports published in connection with scientific meetings. Copies of any closely related manuscripts must be submitted along with the manuscript that is to be considered by the Journal. Authors of all types of articles should follow the general instructions given below. Please see Types of Articles for specific word counts and instructions.
SUBMISSION
COVER LETTER
A covering letter signed by corresponding author should provide full contact details (include the address, telephone number, fax number, and Email address). Please make clear that the final manuscript has been seen and approved by all authors, and that the authors accept full responsibility for the design and conduct of the study, had access to the data, and controlled the decision to publish. There should also be a statement that the manuscript is not under submission elsewhere and has not been published before in any form.
AUTHORS
Authors name will be published exactly as they appear in the manuscript file. Please double-check the information carefully to make sure it is correct.
The names of authors and correspondants and their affiliations cannot be edited, deleted or added after submission. Please make sure they are entered correctly.
AUTHORSHIP
As stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, credit for authorship requires substantial contributions to: (a) conception and design, or analysis and interpretation of data; (b) the drafting of the article or critical revision for important intellectual content and (c) final approval of the version to be published. Authors should meet conditions a, b and c. All authors must sign AUTHORSHIP FORMattesting that they fulfill the authorship criteria. Your submitted manuscript will not be processed unless this form is sent. There should be a statement in manuscript explaining contribution of each author to the work. Those contributors who did not fulfill authorship criteria should be listed in acknowledgments.
Any change in authorship after submission must be approved in writing by all authors.
ASSURANCES
In appropriate places in the manuscript please provide the following items:
“None” is necessary.
TITLE PAGE
With the manuscript, provide a page giving the title of the paper; titles should be concise and descriptive (not declarative). Title page should include an abbreviated running title of 40 characters, the names of the authors, including the complete first names and no more than two graduate degrees, the name of the department and institution in which the work was done, and the institutional affiliation of each author. Also providing ORCID for the first author and correspondence author is necessary. The name, post address, telephone number, fax number, and Email address of the corresponding author should be separately addressed. Any grant support that requires acknowledgment should be mentioned on this page. Word count of abstract and main text as well as number of tables and figures and references should be mentioned on title page. If the work was derived from a project or dissertation, its code should also be stated. For clinical trials, a registry number like Iranian Registry of Clinical Trials (IRCT) should also be provided.
Affiliation model: Department, Institute, City, Country
-Please avoid mentioning your academic degree in your affiliation.
Example: Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
ABSTRACT
Abstract should consist of four paragraphs, labeled Background, Methods, Results, and Conclusion. They should briefly describe the problem being addressed in the study, how the study was performed, the salient results, and what the authors conclude from the results, respectively. Three to 10 keywords may be included. Keywords are preferred to be in accordance with MeSH terms. Find MeSH terms: http://www.ncbi.nlm.nih.gov/mesh
CONFLICT OF INTEREST
Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product is pertinent to the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, a disclosure will appear with the article.
Because the essence of reviews and editorials is selection and interpretation of the literature, the Journal expects that authors of such articles will not have any significant financial interest in a company (or its competitor) that makes a product discussed in the article.
REVIEW AND ACTION
Submitted papers will be examined for the evidence of plagiarism using PlagScan automated plagiarism detection service. Manuscripts are examined by members of the editorial staff, and two thirds are sent to external reviewers. We encourage authors to suggest the names of possible reviewers, but we reserve the right of final selection. Communications about manuscripts will be sent after the review and editorial decision-making process is complete. After acceptance, editorial system makes a final language and scientific edition. No substantial change is permitted by authors after acceptance. It is the responsibility of corresponding author to answer probable questions and approve final version.
COPYRIGHT
Isfahan Cardiovascular research Institute (ICRI) is the owner of all copyright to any original work published by the ARYA Journal. Authors agree to execute copyright transfer forms as requested with respect to their contributions accepted by the Journal. The ICRI have the right to use, reproduce, transmit, derive works from, publish, and distribute the contribution, in the Journal or otherwise, in any form or medium. Authors will not use or authorize the use of the contribution without the Journal Office’ written consent.
JOURNAL STYLE
Use normal page margins (2.5 cm), and double-space throughout.
Tables
Double-space tables and provide a title for each.
Figures
Figures should be no larger than 125 (height) x 180 (width) mm (5 x 7 inches) and should be submitted in a separate file from that of the manuscript. The name of images or figures files should be the same as the order that was used in manuscript (fig1, fig2, etc.). Only JPEG, TIF, GIF and EPS image formats are acceptable with CMYK model for colored image at a resolution of at least 300 dpi. Graphs must have the minimum quality: clear text, proportionate, not 3 dimensional and without disharmonic language. Electron photomicrographs should have internal scale markers.
If photographs of patients are used, either the subjects should not be identifiable or the photographs should be accompanied by written permission to use them. Permission forms are available from the Editorial Office.
Medical and scientific illustrations will be created or recreated in-house. If an outside illustrator creates the figure, the Journal reserves the right to modify or redraw it to meet our specifications for publication. The author must explicitly acquire all rights to the illustration from the artist in order for us to publish the illustration. Legends for figures should be an editable text as caption and should not appear on the figures.
References
The Vancouver style of referencing should be used. References must be double-spaced and numbered as superscripts consecutively as they are cited. References first cited in a table or figure legend should be numbered so that they will be in sequence with references cited in the text at the point where the table or figure is first mentioned. List all authors when there are six or fewer; when there are seven or more, list the first six, then “et al.” In the following some examples are listed:
Units of Measurement
Authors should express all measurements in conventional units, with Système International (SI) units given in parentheses throughout the text. Figures and tables should use conventional units, with conversion factors given in legends or footnotes. In accordance with the Uniform Requirements, however, manuscripts containing only SI units will not be returned for that reason.
Abbreviations
Except for units of measurement, abbreviations are discouraged. Consult Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers (Sixth edition. New York: Cambridge University Press, 1994) for lists of standard abbreviations. Except for units of measurement, the first time an abbreviation appears, it should be preceded by the words for which it stands.
Drug Names
Generic names should generally be used except for studies on comparative effects of different brands. When proprietary brands are used in research, include the brand name and the name of the manufacturer in parentheses in the Methods section.
For any more detail about the writing style for your manuscripts refer to:
Try to prepare your manuscript in accord with the scientific writing checklists available in EQUATOR Network:
http://www.equator-network.org
Type of Articles Considered to be Published in ARYA Atherosclerosis Journal
ARYA Atherosclerosis is a bimonthly peer-reviewed scientific Journal providing academically sound, clinically practical information for physicians, medical scientists and health care providers. ARYA Atherosclerosis is published by Isfahan Cardiovascular Research Institute. Journal editors review articles in fields of atherosclerosis, its risk factors and related diseases.
ORIGINAL RESEARCH
CLINICAL CASES
REVIEW ARTICLES
All review articles undergo the same peer-review and editorial process as original research reports.
OTHER SUBMISSIONS
Ethics: When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). For prospective studies involving human participants, authors are expected to mention about approval of (regional/ national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/ or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals was followed.
Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.
Word Limits:
Original Articles (Quantitative and Qualitative Studies):
Review Articles:
Short Communications:
Case Reports:
Letter to the Editor:
Editorials:
SUBMISSION PREPARATION CHECKLIST
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
To be listed as an author, contributors must meet all four ICMJE authorship criteria. Individuals who do not fulfill all four criteria should be acknowledged separately. Please download the Author Contribution Form, complete it, and upload it along with your submission.
Please note that just correspoding author is permitted to edit the manuscript.
COPYRIGHT NOTICE
Authors who publish with this journal agree to the following terms:
PRIVACY STATEMENT
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
AFTER YOUR SUBMISSION
When a manuscript arrives to ARYA office, a staff member checks it to make sure that all materials required for submission are included. If everything is present, the article is registered in office and referred to the managing editor.
The first step the manuscript makes on its editorial journey is on the desk of the editor-in-chief, who reviews each submission (in his absence this is done by the managing editor) and decides on the basis of its general content whether it is appropriate even for consideration for publication. Each of the remaining scientific manuscripts is assigned to an associate editor with expertise in the subject area covered by the study, who makes an independent assessment of the value and validity of the paper. If the associate editor believes that even with favorable reviews the paper would not be published because it lacks novelty or importance, or if he/she spots a major flaw in experimental design, performance or statistical analysis the manuscript is returned to the authors.
If, on the other hand, the associate editor believes that the paper may merit publication, it is sent to two of our outside reviewers. They are asked to provide a frank evaluation of the scientific validity of the manuscript, insight into its freshness, clinical impact, and timeliness, and an overall opinion of its worthiness for publication. This is the key step in manuscript evaluation. As editors, we are grateful to all our reviewers for their continued contribution to the rating process. We are careful not to refer to them as "referees," which would suggest that the decision to publish a paper rests entirely with them. It does not. The reviewers provide critiques and advice that the editorial staff uses in making decisions. But we, ARYA editorial board, make the decisions. When both outside reviews are returned, the associate editor then assesses the manuscript again, along with the comments of the reviewers. She may seek additional opinions from other reviewers, or may discuss the manuscript at a meeting of the entire editorial staff. At this meeting a decision is made either to reject the paper or to proceed further editorial consideration, including, if appropriate, a formal review of the statistical or experimental methods. In some cases, the editorial staff may recommend additional review by outside reviewers. On completion of this process, the manuscript is usually returned to its authors along with a letter inviting them to revise it and to respond to certain questions. When all the requested information has been received, the manuscript is reconsidered by an associate editor, and it may be discussed again with other members of the editorial staff. We then make our final decision to accept or reject the paper.
We recognize that the peer-review process is not perfect, but we earnestly believe that it is the best way to select and publish the most important medical research. Peer review is labor-intensive and sometimes time-consuming, but without it physicians themselves would have to assess the validity of new medical research and decide when to introduce new treatments into practice.
We do all our efforts to finalize this process in 6 months period for each manuscript. The rejection rate of papers is 40%.
We understand the importance of a submitted manuscript to its authors. We invite you to submit your best research to us; we will treat it with respect, and you can follow it on its journey.
The Editorial Process
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Arya Atherosclerosis journal alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws particularly high rate of similarity with prior publications (plagiarism), or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the Arya Atherosclerosis journal readers are also liable to be rejected at this stage itself.
Manuscripts that are found suitable for publication in Arya Atherosclerosis journal are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. The author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Publication fee will received after completed review via https://researchold.mui.ac.ir/journal-payments. The desired cost is calculated based on the “The publication fees of ARYA Atherosclerosis Journal” table.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online.
The unpublished manuscript is a privileged document. Please protect it from any form of exploitation. Reviewers are expected not to cite a manuscript or refer to the work it describes before it has been published, and to refrain from using the information it contains for the advancement of their own research.
Publication Fee
The publication fees of ARYA Atherosclerosis Journal
|
Type of the article |
Permitted word count* |
The payment fee in Iranian Rial (IRR) |
The payment fee for each 600 excess words (IRR) |
|
Letter to the Editor |
500 |
- |
- |
|
Clinical Case |
1000 |
20,000,000 |
4,000,000 |
|
Short Communication |
1000 |
20,000,000 |
4,000,000 |
|
Original Article |
3000 |
40,000,000 |
8,000,000 |
|
Qualitative Research |
5000 |
40,000,000 |
8,000,000 |
|
Review Article |
5000 |
40,000,000 |
8,000,000 |
*Original Article, Review Article: US $ 500 (for overseas authors); Case Report, Short Communication and Policy Brief: US $ 150 (for overseas authors). Authors of Short Communications, Case Reports, Policy Brief, Original Articles and Review Articles will be charged a minimum fee of 100$ per additional 600 words.
** All the words of the article containing the references; If the total number of figures and tables combined exceeds five, each additional figure or table will be counted as 300 words toward the overall word limit.
*** The authors wishing to use the Fast-Track Service must pay the costs up to 50% more.
****The publication fee for articles whose corresponding author is affiliated with Isfahan University of Medical Sciences will be reduced by 60%.
Author Rights
Retain patent and trademark rights
Retain the rights to use their research data freely without any restriction
Receive proper attribution and credit for their published work
Re-use their own material in new works without permission or payment (with full acknowledgement of the original article):
Use and share their works for scholarly purposes (with full acknowledgement of the original article):
